Microplasmin study shows promising results for two serious eye conditions

Monday, June 7, 2010 - 11:40 in Health & Medicine

A Phase III trial of a drug used for the treatment of vitreomacular adhesion (VMA) and macular hole (MH) revealed key findings for patients diagnosed with these severe conditions which can lead to significant vision impairment...

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net